25Sep/13

Inovio's DNA Tech Generates HIV Monoclonal Antibodies – Drug Discovery & Development

Inovio’s DNA Tech Generates HIV Monoclonal Antibodies
Drug Discovery & Development
Inovio Pharmaceuticals’ DNA plasmid technology is capable of generating therapeutic monoclonal antibodies, according to a new study published in Human Vaccines and Immunotherapeutics. In this study in mice, a prototype monoclonal antibody construct 
Inovio Pharmaceuticals Inc (INO): Inovio talks monoclonal antibodies, DNA Seeking Alpha
Biotech Volume Movers: Inovio Pharmaceuticals Inc (NYSEMKT:INO), Geron Market News Call
Did Inovio Pharmaceuticals Inc (NYSEMKT:INO) find a cure for HIV?GSPInsider

all 9 news articles »

25Sep/13

Bispecific Antibodies market to be worth USD 4.4 billion by 2023, predicts … – 4-traders (press release)

Bispecific Antibodies market to be worth USD 4.4 billion by 2023, predicts
4-traders (press release)
Roots Analysis has announced addition of the “Bispecific Antibody Therapeutics Market, 2013-2023” report to their offering. The report provides an extensive study of this emerging field, including detailed sales forecast of molecules undergoing

and more »